Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein

British Journal of Cancer

Volumn 88, Issue 4, 2003, Pages 636-643

  Menendez S ^a   Higgins, M ^a   Berkson, R G ^a   Edling, C ^a   Lane, D P ^a   Lain S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Human Mdm2; Leptomycin B; Limited proteolysis; p53; Proteasome

Indexed keywords

LEPTOMYCIN B; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN MDM2; PROTEIN P53;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LINE; CELL NUCLEUS; DRUG EFFECT; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACIDS, UNSATURATED; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037463228     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600752     Document Type: Article

References (42)

1. Argentini M, Barboule N, Wasylyk B (2001) The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene 20: 1267-1275
2. Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wildtype p53 activity. EMBO J 12: 461-468
3. Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW (2001) Defining the molecular basis of Arf and Hdm2 interactions. J Mol Biol 314: 263-277
4. Chen J, Marechal V, Levine AJ (1993) Mapping of the p53 and Mdm-2 interaction domains. Mol Cell Biol 13: 4107-4114
5. Chen J, Wu X, Lin J, Levine AJ (1996) mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 16: 2445-2452
6. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945-8951
7. Freedman DA, Levine AJ (1998) Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol 18: 7288-7293
8. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
9. Hietanen S, Lain S, Krausz E, Blattner C, Lane DP (2000) Activation of p53 in cervical carcinoma cells by small molecules. Proc Natl Acad Sci USA 97: 8501-8506
10. Hollstein M, Hergenhahn M, Yang Q, Bartsch H, Wang ZQ, Hainaut P (1999) New approaches to understanding p53 gene tumor mutation spectra. Mutat Res 431: 199-209
11. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27
12. Honda R, Yasuda H (2000) Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19: 1473-1476
13. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
14. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, Yoshida M, Horinouchi S (1999) Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 96: 9112-9117
15. Lain S, Midgley C, Sparks A, Lane EB, Lane DP (1999a) An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res 248: 457-472
16. Lain S, Xirodimas D, Lane DP (1999b) Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function. Exp Cell Res 253: 315-324
17. Lane DP, Lain S (2002) Therapeutic exploitation of the p53 pathway. Trends Mol Med 8: S38-S42
18. Lin L, DeMartino GN, Greene WC (1998) Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92: 819-828
19. Lin L, DeMartino GN, Greene WC (2000) Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50- p105 heterodimers and is required for effective p50 production. EMBO J 19: 4712-4722.
20. Lin L, Ghosh SA (1996) Glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol 16: 2248-2254
21. Lohrum MA, Ashcroft M, Kubbutat MH, Vousden KH (2000) Identification of a cryptic nucleolar-localization signal in MDM2. Nat Cell Biol 2: 179-181
22. Lu X, Burbidge SA, Griffin S, Smith HM (1996) Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Oncogene 13: 413-418
23. Middeler G, Zerf K, Jenovai S, Thulig A, Tschodrich-Rotter M, Kubitscheck U, Peters R (1997) The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14: 1407-1417
24. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP (2000) An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19: 2312-2323
25. Newlands ES, Rustin GJ, Brampton MH (1996) Phase I trial of elactocin. Br J Cancer 74: 648-649
26. Ostrowska H, Wojcik C, Wilk S, Omura S, Kozlowski L, Stoklosa T, Worowski K, Radziwon P (2000) Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome. Int J Biochem Cell Biol 32: 747-757
27. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785
28. Picksley SM, Vojtesek B, Sparks A, Lane DP (1994) Immunochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9: 2523-2529
29. Pirollo KF, Bouker KB, Chang EH (2000) Does p53 status influence tumor response to anticancer therapies? Anticancer Drugs 11: 419-432
30. Pochampally R, Fodera B, Chen L, Lu W, Chen J (1999) Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J Biol Chem 274: 15271-15277
31. Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21: 267-271
32. Roberts BJ, Hamelehle KL, Sebolt JS, Leopold WR (1986) In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114, 721). Cancer Chemother Pharmacol 16: 95-101
33. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ (1998) Nucleocytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 17: 554-564
34. Smart P, Lane EB, Lane DP, Midgley C, Vojtesek B, Lain S (1999) Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B. Oncogene 18: 7378-7386.
35. Soussi T (2000) The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann NY Acad Sci 910: 121-137
36. Stephen CW, Helminen P, Lane DP (1995) Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J Mol Biol 248: 58-78
37. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18: 1660-1672
38. Tao W, Levine AJ (1999) Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc Natl Acad Sci USA 96: 3077-3080
39. Vousden KH (2002) Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602: 47-59
40. Xirodimas D, Saville MK, Edling C, Lane DP, Laín S (2001a) Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20: 4972-4983.
41. Xirodimas DP, Stephen CW, Lane DP (2001b) Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp Cell Res 270: 66-77.
42. Zhang Y, Xiong Y (2001) A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292: 1910-1915.